Neurosense Therapeutics News - June 2026
🟢 NRSN up 1.58% today on positive PrimeC Alzheimer's biomarker findings
• NeuroSense Therapeutics (NRSN) is trading up 1.58% today at $0.77 following the announcement of positive biomarker findings from its Phase 2 study of PrimeC...
🟢 Neurosense Therapeutics Ltd is trading 5.7% up today amid insider buying by CEO and CFO
• NeuroSense Therapeutics Ltd is trading at $0.74, up 5.7% in pre-market sessions, potentially driven by recent insider buying. • On June 16, 2026, CEO Alon...
🟢 Neurosense Therapeutics Ltd. (NRSN) Surges 10% on Insider Buying by CEO and CFO
Neurosense Therapeutics Ltd. (NRSN) traded at $0.77 in after-hours, marking a 10% increase from its regular session close of $0.70. This significant movement...